Patent details

EP1727539 Title: USE OF ROTIGOTINE FOR TREATING AND PREVENTING PARKINSON'S PLUS SYNDROME

Basic Information

Publication number:
EP1727539
PCT Application Number:
PCT/EP/2005/003013
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP057286866
PCT Publication Number:
WO/2005/092331
First applicant's nationality:
Translation Language:
EPO Publication Language:
German
English Title of Invention:
USE OF ROTIGOTINE FOR TREATING AND PREVENTING PARKINSON'S PLUS SYNDROME
French Title of Invention:
UTILISATION DE ROTIGOTINE POUR TRAITER ET PREVENIR LE SYNDROME PARKINSON PLUS
German Title of Invention:
VERWENDUNG VON ROTIGOTIN ZUR BEHANDLUNG UND PRÄVENTION DES PARKINSON-PLUS-SYNDROMS
SPC Number:

Dates

Filing date:
22/03/2005
Grant date:
31/10/2007
EP Publication Date:
31/10/2007
PCT Publication Date:
06/10/2005
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
06/12/2006
EP B1 Publication Date:
31/10/2007
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
22/03/2008
Expiration date:
22/03/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/03/2005
 
 

Name:
SCHWARZ PHARMA AG
Address:
Alfred-Nobel-Strasse 10, 40789 Monheim/Rhld., Germany (DE)

Inventor

Name:
SCHELLER Dieter
Address:
Germany (DE)

Priority

Priority Number:
102004014841
Priority Date:
24/03/2004
Priority Country:
Germany (DE)

Classification

Main IPC Class:
A61K 31/381;
Filing date Document type Number of pages